TRUEX PAUL F 4
4 · CymaBay Therapeutics, Inc. · Filed Sep 26, 2017
Insider Transaction Report
Form 4
TRUEX PAUL F
Director
Transactions
- Award
Stock Option (right to buy)
2017-09-22+7,500→ 7,500 totalExercise: $7.47Exp: 2017-09-21→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017, subject to the Reporting Person's continuous service to the Issuer as of each such date. The option allows for early exercise by the Reporting Person.